EROSIVE STRUCTURAL CHANGES AND THE IMPACT OF ANTI-TNFA THERAPY IN THE SPINE OF PATIENTS WITH ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Baraliakos, X. [1 ]
Listing, J. [2 ]
Rudwaleit, M. [3 ]
Sieper, J. [3 ]
Braun, J. [1 ]
机构：
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, D-4690 Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Univ Med Berlin, Dept Rheumatol, Berlin, Germany
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2010年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：606 / 607
页数：2
相关论文
共 50 条
  • [41] Can structural changes be reduced in ankylosing Spondylitis (AS)
    Sieper, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 30 - 31
  • [42] DISCONTINUATION OF ANTI-TNF-ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Vasiljeva, H. G.
    Elonakov, A. V.
    Gorenkov, R. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1024 - 1024
  • [43] Anti-TNF-α therapy in ankylosing spondylitis
    Wendling, D
    Toussirot, E
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (07) : 1497 - 1507
  • [44] THE INFLUENCE OF SMOKING ON RESPONSE TO ANTI TNF THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Anghel, D.
    Jurcut, C.
    Anghel, A.
    Negru, M. M.
    Savulescu, A. E.
    Panturu, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S67 - S68
  • [45] Physical therapy in anti-TNF treated patients with ankylosing spondylitis
    Dubey, S. G.
    Leeder, J.
    Gaffney, K.
    RHEUMATOLOGY, 2008, 47 (07) : 1100 - 1101
  • [46] SERUM INDIAN HEDGEHOG (IHH) LEVELS ARE INCREASED IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS). ANTI-TNFA TREATMENT DECREASES SERUM IHH LEVELS IN PATIENTS WITH AS AND AFFECTS THE EXPRESSION OF FUNCTIONAL TARGET GENES IN A CELL LINE MODEL
    Filippopoulou, A.
    Daoussis, D.
    Liossis, S. -N.
    Bouris, P.
    Klavdianou, K.
    Karamanos, N.
    Andonopoulos, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 134 - 134
  • [47] A BASELINE GENE EXPRESSION-BASED PROGNOSTIC FOR ANTI-TNFa THERAPY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Sakaram, Suraj
    He, Yudong
    Sweeney, Timothy
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S8 - S8
  • [48] Two-Year Follow-up of Patients on Anti-TNFa Therapy Substituted to Certolizumab: SAVANT 2
    Motlis, Andrew
    Boktor, Moheb
    Jordan, Paul
    Alexander, Steven
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S317 - S317
  • [49] Lympocytosis in patients with inflammatory bowel disease treated with anti-TNFa agents: is it significant?
    Soufleris, K.
    Kafalis, N.
    Charalampidis, M.
    Fasoulas, K.
    Pilpilidis, I.
    Lazaraki, G.
    Tzilves, D.
    Markala, D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S322 - S322
  • [50] DISCONTINUATION OF ANTI-TNFA IN PATIENTS WITH PSORIATIC ARTHRITIS: A SINGLE-CENTER EXPERIENCE
    Graceffa, D.
    Lora, V.
    Cristaudo, A.
    Elia, F.
    Morrone, A.
    Bonifati, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1318 - 1318
12345